Effect of ursodeoxycholic acid in acute viral hepatitis

Journal of Clinical Gastroenterology

Volumn 28, Issue 3, 1999, Pages 249-253

  Marinho, Rui T ^a   Moura, Miguel C ^a   Pedro, Maríla ^a   Ramalho, Fernando J ^a   Velosa, José F ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Acute disease; Hepatitis B; Hepatitis drug treatment; Hepatitis, viral; Ursodeoxycholic acid

Indexed keywords

URSODEOXYCHOLIC ACID;

ACUTE HEPATITIS; ADULT; ARTICLE; COMORBIDITY; DISEASE COURSE; DRUG EFFECT; FEMALE; FOLLOW UP; GALLSTONE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHOLAGOGUES AND CHOLERETICS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; TRANSFERASES; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 0344097337     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199904000-00013     Document Type: Article

References (32)

1. Beasley R, Hwang L, Lin C, Chien C. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129-33.
2. Velosa J, Marinho R, Gouveia A, Ramalho F, Carneiro Moura M. Factores de risco parao carcinoma hepatocelular em doentes com cirrose hepática. GE J Português Gastroenterol 1994;1:3-13.
3. Murray D. Vaccine-preventable diseases and medical personnel Arch Intern Med 1990;150:25-6.
4. Velosa J, Marinho R, Ramalho F, Carneiro de Moura M. Inmunidad para el virus da la hepatitis B em personal hospitalario. Indicaciones para vacunación. Gastroenterol Hepatol 1988;11:395-9.
5. Niu M, Davis D, Ellenberg S. Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 1996;15:771-6.
6. Harpaz R, Seidlein L, Averhoff F, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996;334:549-54
7. Gerberding J. The infected health care provider. N Engl J Med 1996;334:594-5.
8. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995;13(Suppl 1):S47-9.
9. Lee D, Carrillo L, Fleming L. Epidemiology of hepatitis B vaccine acceptance among urban paramedics and emergency medical technicians. Am J Infect Control 1997;25:421-3.
10. Scapa E, Karpuch J, Waron M, Eschar J. Attitude of hospital personnel toward hepatitis B vaccination. Am J Gastroenterol 1989;84:400-2.
11. Israsena S, Kamolratanakul P, Sakulramrung R. Factors influencing acceptance of hepatitis B vaccination by hospital personnel in an area hyperendemic for hepatitis B. Am J Gastroenterol 1992;87:1807-9.
12. Duval B, Boulianne N, de Serres G, et al. Should children with isolated anti-HBs or anti-HBc be immunized against hepatitis B virus? JAMA 1997;278:1064.
13. Kessler H, Harris A, Payne J, Hudson E, Potkin B, Levin S. Antibodies to hepatitis B surface antigen as the sole hepatitis B marker in hospital personnel. Ann Intern Med 1985;103:21-6.
14. Kane M, Hadler S, Maynard J. Antibody to hepatitis B surface antigen and screening before hepatitis B vaccination. Ann Intern Med 1985;103:791-3.
15. Draelos M, Morgan T, Schifman R, Sampliner R. Significance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccination. JAMA 1987;258:1193-5.
16. Lok A, Lai C, Wu P. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988;8:766-70.
17. Lecour H, Ribeiro A, Amaral I. Prevalência do antigénio de superfície da hepatite B na população portuguesa. O Médico 1981;98:326-34.
18. Thomas D, Factor S, Kelen G, Washington A, Taylor E, Quinn T. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med 1993;153:1705-12.
19. McMahon B, Helminiak C, Wainwright R, Bulkow L, Trimble B, Wainwright K. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 1992;92:254-6.
20. Jilg W, Schmidt M, Deinhardt F, Zachoval R. Hepatitis B vaccination: how long does protection last? Lancet 1984;2:458.
21. Jilg W, Schmidt M, Deinhardt F. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol 1988;6:201-6.
22. Nommensen F, Go S, MacLaren D. Half-life of HBs antibody after hepatitis B vaccination: an aid to timing of booster vaccination. Lancet 1989;2:847-9.
23. Hadler S, Francis D, Maynard J, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315:209-14.
24. Hattum J, Maikoe T, Poel J, Gast G. Persistence of immune memory in responders to hepatitis B vaccination who subsequently lost anti-HBs titer. Hepatology 1990;12:S885.
25. Wood R, MacDonald L, White K. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993;270:2935-9.
26. Weber D, Rutala W, Samsa G, Santimaw J, Lemon S. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985;254:3187-9.
27. Collier A, Corey L, Murphy V, Handsfield H. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 1988;109:101-5.
28. Alper C, Kruskall M, Marcus-Bagley D, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989;321:708-12.
29. Jilg W, Schmidt M, Deinhardt F. Immune response to hepatitis B revaccination. J Med Virol 1988;24:377-84.
30. Coursaget P, Leboulleux D, Soumare M, et al. Twelve-year followup study of hepatitis B immunization of Senegalese infants. J Hepatol 1994;21:250-4.
31. Whittle H, Maine N, Pilkington J, et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 1995;345:1089-92.
32. Zuckerman J, Sabin C, Craig F, Williams A, Zuckerman A. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to a standard vaccine: randomised double blind dose-response study. BMJ 1997;314:329-33.